S100A9 and myelodysplastic syndrome: This impact of S100A8 and S100A9 proteins on hematopoietic microenvironment has been highlighted by a transcriptional analysis of mesenchymal cells CD271+ of healthy donors compared to different pre-leukemic models (SBDS −/− mouse; patients low risk MDS patients Blackfan-Diamond anemia) [55].